Zepbound 12.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FSDZP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $59,157
Award facts
- Contract value 100% obligated
- $59,156.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at approximately $59.2K to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Zepbound (tirzepatide) 12.5 mg/0.5 mL injectable pens. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award through open competition. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of September 3, 2025. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9M global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp operates as a major pharmaceutical distributor and critical federal medical procurement vendor serving military and veteran healthcare systems through the Defense Logistics Agency and Defense Health Agency. The company maintains an extensive portfolio of federal contract awards covering diverse pharmaceutical products including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. The award of Zepbound reflects AmerisourceBergen's continued role in providing specialty medications to support federal healthcare needs, consistent with the company's demonstrated capability to fulfill open competition requirements across a broad spectrum of medical commodities and price points.
Quick answers
Who was awarded contract SPE2DB25FSDZP?
SPE2DB25FSDZP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FSDZP worth?
The government has obligated $59,157 on SPE2DB25FSDZP.
Is contract SPE2DB25FSDZP an order under another contract?
Yes. SPE2DB25FSDZP is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB25FSDZP competed?
The extent of competition for SPE2DB25FSDZP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award